| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
36,010,000 |
| Market
Cap: |
467.77(M) |
| Last
Volume: |
129,261 |
Avg
Vol: |
128,900 |
| 52
Week Range: |
$9.69 - $21.36 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Orthofix Medical is a medical device company. Co.'s Global Spine segment provides implantable medical devices, biologics, and other regenerative solutions. This segment's product categories include: Bone Growth Therapies, which manufactures, distributes, and provides support services for bone growth stimulation devices; Spinal Implants, which designs, develops and markets a portfolio of motion preservation and fixation implant products; and Biologics, which provides a portfolio of products and tissue forms. Co.'s Global Orthopedics segment provides products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,500 |
7,500 |
| Total Buy Value |
$0 |
$0 |
$101,025 |
$101,025 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
8,243 |
12,505 |
| Total Sell Value |
$0 |
$0 |
$156,617 |
$232,268 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
2 |
3 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Elting Kimberley A. |
Chief Legal & Admin Officer |
• – – |
2018-09-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,714 |
16,290 |
|
- |
|
| Mason Brad |
CEO |
• • – |
2018-09-05 |
4 |
AS |
$53.02 |
$132,555 |
D/D |
(2,500) |
147,841 |
|
- |
|
| Doug Rice |
CFO |
• – – |
2018-09-04 |
4 |
D |
$53.35 |
$13,071 |
D/D |
(245) |
36,907 |
|
- |
|
| Mason Brad |
CEO |
• • – |
2018-08-07 |
4 |
AS |
$51.41 |
$133,168 |
D/D |
(2,500) |
150,341 |
|
- |
|
| Marks Lilly |
Director |
– • – |
2018-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900 |
16,929 |
|
- |
|
| Paolucci Michael E |
Director |
– • – |
2018-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900 |
11,429 |
|
- |
|
| Sainz Maria |
Director |
– • – |
2018-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900 |
32,167 |
|
- |
|
| Sicard John |
Director |
– • – |
2018-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900 |
2,900 |
|
- |
|
| Lukianov Alexis V |
Director |
– • – |
2018-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900 |
6,966 |
|
- |
|
| Matricaria Ronald A |
Director |
– • – |
2018-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
5,274 |
106,887 |
|
- |
|
| Hinrichs James F. |
Director |
– • – |
2018-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900 |
29,197 |
|
- |
|
| Faulstick Luke T |
Director |
– • – |
2018-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900 |
10,629 |
|
- |
|
| Mason Brad |
CEO |
• • – |
2018-07-10 |
4 |
AS |
$58.62 |
$146,554 |
D/D |
(2,500) |
134,290 |
|
- |
|
| Niemann Bradley V. |
President of Global Spine |
• – – |
2018-07-03 |
4 |
AS |
$56.94 |
$641,435 |
D/D |
(11,250) |
26,992 |
|
- |
|
| Niemann Bradley V. |
President of Global Spine |
• – – |
2018-07-03 |
4 |
OE |
$21.78 |
$272,975 |
D/D |
11,250 |
38,242 |
|
- |
|
| Niemann Bradley V. |
President of Global Spine |
• – – |
2018-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,989 |
26,992 |
|
- |
|
| Fujikawa Raymond |
President Spine Fixation |
• – – |
2018-06-20 |
4 |
AS |
$60.16 |
$1,941,202 |
D/D |
(32,243) |
12,859 |
|
- |
|
| Fujikawa Raymond |
President Spine Fixation |
• – – |
2018-06-20 |
4 |
OE |
$21.78 |
$418,075 |
D/D |
18,750 |
45,102 |
|
- |
|
| Bianchi Davide |
President Extremity Fixation |
• – – |
2018-06-19 |
4 |
AS |
$60.00 |
$885,720 |
D/D |
(14,762) |
41,260 |
|
- |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2018-06-18 |
4 |
AS |
$58.63 |
$1,764,301 |
D/D |
(30,000) |
36,844 |
|
- |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2018-06-18 |
4 |
OE |
$25.01 |
$789,700 |
D/D |
30,000 |
66,844 |
|
- |
|
| Mason Brad |
CEO |
• • – |
2018-06-14 |
4 |
AS |
$57.95 |
$144,864 |
D/D |
(2,500) |
143,221 |
|
- |
|
| Matricaria Ronald A |
Director |
– • – |
2018-05-03 |
4 |
B |
$51.97 |
$519,724 |
D/D |
10,000 |
101,613 |
2.39 |
- |
|
| Fujikawa Raymond |
President Spine Fixation |
• – – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,308 |
26,352 |
|
- |
|
| Niemann Bradley V. |
President Biostim |
• – – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,528 |
21,296 |
|
- |
|
697 Records found
|
|
Page 10 of 28 |
|
|
0.11 (0.84%) 
